美克
Search
logo
News Center
NEWS CENTER
/
Newsroom

Company news

Industry trends

2023
03-27
小黑点

Medomics has launched Candida albicans/ Trichomonas vaginalis/ Gardnerella vaginalis antigen Combo Test Kit (LFIA)

 Reproductive tract infection is an important part of systemic infection and has become a major public health problem in the world. Recent studies have shown that reproductive tract infection is closely related to tumor occurrence, infertility, ectopic pregnancy, premature rupture of membranes and premature delivery and so on. Almost all reproductive tract infections are accompanied by changes of genital tract microenvironment.   There are several common pathogens which are easy to cause gynecologic diseases in women:   1)Candida albicans is a major fungal pathogen of humans. It exists as a commensal in the oral cavity, gut or genital tract of most individuals, constrained by the local microbiota, epithelial barriers and immune defenses. Their perturbation can lead to fungal outgrowth and the development of mucosal infections such as oropharyngeal or vulvovaginal candidiasis, and patients with compromised immunity are susceptible to life-threatening systemic infections.   2)Trichomonas vaginalis is a motile organism with a size comparable to a white blood cell. It has at least 4 flagella that provide undulating motility. The organism resides in the lumen of the urogenital tract. The organism releases cytotoxic proteins that destroy the epithelial lining. During an infection, the vaginal pH usually increases.   3)Gardnerella vaginalis is an anaerobic bacterium that resides in the normal vaginal flora. Normally, vaginal flora is predominated by the lactobacilli species, but when organisms such as gardnerella begin to overgrow and become the dominant species, this leads to bacterial vaginosis (BV). Bacterial vaginosis is characterized by the presence of clue cells, which are epithelial cells of the cervix that are covered with rod-shaped bacteria. According to statistics, 11% of women have BV detected during physical examination, and 36% - 60% among vaginitis patients in gynecological clinics.     To meet the needs of market, Jiangsu Medomics Medical Technology Co., Ltd. has released a new product named Candida albicans/Trichomonas vaginalis/Gardnerella vaginalis antigen Combo Test Kit (LFIA). The test kit uses a double antibody sandwich method to detect Candida albicans, Trichomonas vaginalis, and Gardnerella vaginalis by latex microsphere immunochromatography, and is suitable for women with clinical symptoms of gynecological inflammation or suspected gynecological inflammation.       The products have following advantages:           On-site screening & quick results in 15 mins Low professional and training requirement    Unaffected by medication                                Obtain pathogen antigen with high specificity   Please CONTACT us if you are interested. We will be ready to provide you with the best possible service. 
查看详情
2022
11-18
小黑点
2022
08-10
小黑点

Medomics at MEDICA 2022

Medomics will attend Düsseldorf International Medical Fair in Germany in Nov. 14th - 17th, 2022.  MEDICA is the leading international trade fair for medical sector. It is a very attractive event: more than 5100 exhibitors from 66 nations.
查看详情
2022
07-19
小黑点

Medomics Medical contributes to global epidemic prevention and control, and has been approved two more certifications

      On June 28, 2022, Medomics Medical successfully obtained the TGA SARS-CoV-2 Antigen Test Kit (LFIA) Product Self-Test Certificate. This is the third certificate that Medomics Medical has obtained for this rapid test combo products in the Australian market after the professional version and the saliva oral self-test version.  
查看详情
2022
07-19
小黑点

Medomics Medical has awarded the EU CE certificate of the SARS-CoV-2 and Influenza A/B Antigen Combo rapid Test Kit (LFIA)

      On May 24th, Medomics Medical independently developed SARS-CoV-2 &Influenza A/B Antigen Combo Rapid Test Kit(LFIA) that can be used for this self test rapid combo  has obtained the CE self-test certificate issued by PCBC (1434), which means that Medomics Medical's triple inspection and self-test products have fully complied with the IVDD directive and the latest EU MDCG2021-21 Regulatory requirements, it can be sold in the EU and countries that recognize the EU CE self-test certificate. Medomics is the third IVD company to obtain the CE certificate of triple inspection and self-test, and the first company in the world to pass the audit and certification of this self test rapid combo inspection and self-test certificate by the well-known announcement agency UL.  
查看详情
APALT

FOLLOW MEDOMICS

APALT

Product Center

Contact Us

Phone: (+86) 025 - 58601060

E-mail: overseas@medomics-dx.com
Address:3 / F, Building D, Phase II, Zhongdan Ecological Life Science Industrial Park, 3-1 Xinjinhu Road, Jiangbei New District, Nanjing

 

Jiangsu Medomics Medical Technology Co,Ltd    Powered By www.300.cn